Disclaimer

Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.

US: CAUTION – Investigational Device. Limited by Federal (or United States) law to investigational use.

News & Events

Press
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
March 28, 2024
JenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The Lancet
Read More
Press
JenaValve’s Trilogy THV System Highlighted at CRT 2024
March 19, 2024
JenaValve’s Trilogy THV System Highlighted at CRT 2024
Read More
Press
JenaValve Announces Partnership with the ASE to Advance Detection and Diagnosis of AR
November 16, 2023
JenaValve Announces Partnership with the ASE to Advance Detection and Diagnosis of AR
Read More
Press
JenaValve
October 24, 2023
Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy Endpoints
Read More
Press
ALIGN-AR Trial Data to be Presented as Late-Breaker at TCT 2023
September 19, 2023
ALIGN-AR Trial Data to be Presented as Late-Breaker at TCT 2023
Read More
Press
JenaValve
September 14, 2023
JenaValve Appoints Shlomi Nachman to Board of Directors
Read More
Press
JenaValve
June 10, 2023
egnite & JenaValve Partnership
Read More
Press
JenaValve
May 18, 2023
1st Trilogy Implanted in Asia
Read More
Press
JenaValve
April 30, 2023
Ken MacLeod joins Board of Directors
Read More

Upcoming Events

View All